机构地区:[1]Department of Physiology, College of Korean Medicine, Sangji University, Wonju-si Gangwon-do 220-702, Republic of Korea [2]Department of Pharmacology, College of Korean Medicine, Sangji University, Wonju-si Gangwon-do 220-702, Reoublic of Korea
出 处:《Chinese Journal of Integrative Medicine》2017年第8期611-616,共6页中国结合医学杂志(英文版)
基 金:Supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Science,ICT & Future Planning(NRF-2016R1C1B2011827)
摘 要:Objective:To evaluate the efficacy of Bawu Decoction(八物汤,BWD,Palmul-tang in Korean)against benign prostatic hyperplasia(BPH).Methods:Twenty-four male Wistar rats were divided into 4 groups,with 6 rats in each group.The 4 study groups included sham-operated group(CON),BPH model group,finasteride-treated group,and BWD-treated group.All the groups except CON group received a subcutaneous injection of 10 mg/kg of testosterone,while CON group received saline.Finasteride at a dose of 5 mg/kg was administered to the finasteride-treated group for a period of 4 weeks.BWD group received BWD at a dose of 200 mg/kg for 4 weeks.The prostatic weight,prostate weight to body weight ratio,relative prostate weight ratio,serum testosterone and dihydrotestosterone(DHT)level,and histological analysis of prostatic tissue were analyzed.Results:Compared to BPH model group,BWD administration was associated with reductions in prostatic weight,prostate and relative prostate weight ratio weight to body weight ratio(P〈0.05).The concentration of serum testosterone and DHT were higher in BPH group compared with CON group(P〈0.05).Administration of finasteride and BWD suppressed the elevation of serum testosterone and DHT levels significantly(both P〈0.05).In addition,BWD suppressed the growth of prostatic tissue(P〈0.05).Conclusion:BWD has suppressant effects on development of BPH through inhibition of serum testosterone and DHT.Objective:To evaluate the efficacy of Bawu Decoction(八物汤,BWD,Palmul-tang in Korean)against benign prostatic hyperplasia(BPH).Methods:Twenty-four male Wistar rats were divided into 4 groups,with 6 rats in each group.The 4 study groups included sham-operated group(CON),BPH model group,finasteride-treated group,and BWD-treated group.All the groups except CON group received a subcutaneous injection of 10 mg/kg of testosterone,while CON group received saline.Finasteride at a dose of 5 mg/kg was administered to the finasteride-treated group for a period of 4 weeks.BWD group received BWD at a dose of 200 mg/kg for 4 weeks.The prostatic weight,prostate weight to body weight ratio,relative prostate weight ratio,serum testosterone and dihydrotestosterone(DHT)level,and histological analysis of prostatic tissue were analyzed.Results:Compared to BPH model group,BWD administration was associated with reductions in prostatic weight,prostate and relative prostate weight ratio weight to body weight ratio(P〈0.05).The concentration of serum testosterone and DHT were higher in BPH group compared with CON group(P〈0.05).Administration of finasteride and BWD suppressed the elevation of serum testosterone and DHT levels significantly(both P〈0.05).In addition,BWD suppressed the growth of prostatic tissue(P〈0.05).Conclusion:BWD has suppressant effects on development of BPH through inhibition of serum testosterone and DHT.
关 键 词:benign prostatic hyperplasia Bawu Decotion Palmul-tang FINASTERIDE testosterone dihydrotesterone RAT
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...